Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Histogen Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 2.74M | 2.84M | +99.0K (+3.6%) |
| Value | $2.99M | $2.15M | −$835.3K (−27.9%) |
New holders (4)
Institutions that held Histogen Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 52,522 | $40.0K | 0.01% |
| Two Sigma Advisers, LP | 13,400 | $10.0K | 0.00% |
| Susquehanna International Group, LLP | 11,458 | $9.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,702 | $5.00K | 0.00% |
Sold out (6)
Institutions that held Histogen Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Renaissance Technologies LLC | 92,721 | $101.0K |
| Goldman Sachs Group Inc | 31,344 | $34.0K |
| UBS Group AG | 8,097 | $9.00K |
| Citigroup Inc | 90 | $0 |
| Salem Investment Counselors Inc | 20 | $0 |
| Royal Bank of Canada | 100 | $0 |